$1,844.24
Cargos de importación Incluido

Artículo:
$1,530.72
Cargos estimados de importación:
$313.52
Total:
$1,844.24

Recopilaremos los Cargos de importación en el momento de tu compra y los utilizaremos para cubrir los impuestos y aranceles aplicables a la importación. Más información. El total mostrado arriba puede cambiar dependiendo de la opción de envío que seleccionaste y de los artículos en tu carrito al finalizar la compra.

Disponible
Este producto vendido por Amazon Estados Unidos es importado y puede ser diferente a la versión disponible en México. Aplican términos y condiciones separados. Más información

Amazon Estados Unidos

  • Los productos de Amazon Internacional estan sujetos a términos y condiciones separados; son vendidos desde el extranjero por vendedores extranjeros y pueden ser diferentes a las versiones disponibles en México incluyendo su configuración, calificación de edad, idioma del producto, etiquetado e instrucciones.
  • Es posible que la garantía del fabricante no sea válida en México.
  • Este producto importado no es elegible para factura o CFDI. Sin embargo, puedes acceder a tu recibo desde los detalles del pedido.
$$1,844.24 () Incluye opciones seleccionadas. Incluye el pago mensual inicial y las opciones seleccionadas. Detalles
Precio
Subtotal
$$1,844.24
Subtotal
Desglose del pago inicial
Se muestran el costo de envío, la fecha de entrega y el total del pedido (incluidos los impuestos) al completar la compra.
Envío desde
Amazon Estados Unidos
Envío desde
Amazon Estados Unidos
Devoluciones
Devolución durante 30 días a partir de que recibes el producto
Devolución durante 30 días a partir de que recibes el producto
Los productos se deben devolver en el mismo estado en el que se recibieron dentro de los 30 días siguientes a partir de su entrega. Puedes recibir un reembolso parcial o ningún reembolso si el producto ha sido usado, dañado, o no es el producto original.
Leer la política completa de devoluciones
Devoluciones
Devolución durante 30 días a partir de que recibes el producto
Los productos se deben devolver en el mismo estado en el que se recibieron dentro de los 30 días siguientes a partir de su entrega. Puedes recibir un reembolso parcial o ningún reembolso si el producto ha sido usado, dañado, o no es el producto original.
Leer la política completa de devoluciones
Pago
Transacción segura
La transacción es segura
Trabajamos duro para proteger tu seguridad y privacidad. Nuestro sistema de seguridad de pagos cifra tu información durante la transmisión. No compartimos los datos de tu tarjeta de crédito con vendedores externos ni vendemos tu información a terceros. Más información
Pago
Transacción segura
Trabajamos duro para proteger tu seguridad y privacidad. Nuestro sistema de seguridad de pagos cifra tu información durante la transmisión. No compartimos los datos de tu tarjeta de crédito con vendedores externos ni vendemos tu información a terceros. Más información
Imagen del logotipo de la app de Kindle

Descarga la app de Kindle gratuita y comienza a leer libros Kindle al instante en tu smartphone, tablet o computadora no se requiere un dispositivo Kindle.

Lee instantáneamente en tu navegador con Kindle para web.

Con la cámara de tu teléfono celular: escanea el siguiente código y descarga la app de Kindle.

Código QR para descargar la app de Kindle

Seguir al autor

David Healy
Seguir
Se produjo un error. Intenta enviar tu solicitud de nuevo más tarde.

The Creation of Psychopharmacology Pasta dura – 1 abril 2002

Edición Inglés por David Healy (Autor)
5.0 5.0 de 5 estrellas 12 calificaciones
Ver todos los formatos y ediciones
en cualquier 2 artículos calificados
Hasta 24 meses de $103.50 Ver 2 planes de pago
Seleccione pagar con Kueski Pay. Hasta 12 quincenas disponibles, no se requiere tarjeta de crédito para su aprobación. Conocer más

Seleccione pagar con su tarjeta de crédito. Hasta 24 meses disponibles en compras elegibles. Conocer más

Plazo Por mes costo de financiamiento Total
24 meses $103.50* $639.95 $2,484.19
18 meses $128.99* $477.66 $2,321.90
12 meses $182.11* $341.18 $2,185.42
9 meses $239.34* $309.83 $2,154.07
6 meses $345.18* $226.84 $2,071.08
3 meses $663.31* $145.70 $1,989.94
* Incluye costo de financiamiento mensual. No incluye los costos de envío (estos serán incluidos antes de realizar el pago).
{"desktop_buybox_group_1":[{"displayPrice":"$1,844.24","priceAmount":1844.24,"currencySymbol":"$","integerValue":"1,844","decimalSeparator":".","fractionalValue":"24","symbolPosition":"left","hasSpace":false,"showFractionalPartIfEmpty":true,"offerListingId":"3A4J2mH%2F3T4i6FAh5xnscOWecqa6gG3oC4%2F1dP2cqROGDaGKJDdBTD87aJLy%2BZKuQM%2F061Az%2B6qf8Zw0mMMeTeHdoGQ9lAEwD%2BWZhp6Y%2B9jz7KttFZGyWc5Wog4qWepyDiH56svdoZWnI99NED2yXMUXPqYdBkkc4Xo6caTlZOrwMCs69u%2BtWTvCGxAbBcO0","locale":"es-MX","buyingOptionType":"NEW","aapiBuyingOptionIndex":0}]}

Opciones de compra y productos Plus

David Healy follows his widely praised study, The Antidepressant Era, with an even more ambitious and dramatic story: the discovery and development of antipsychotic medication. Healy argues that the discovery of chlorpromazine (more generally known as Thorazine) is as significant in the history of medicine as the discovery of penicillin, reminding readers of the worldwide prevalence of insanity within living memory.

But Healy tells not of the triumph of science but of a stream of fruitful accidents, of technological discovery leading neuroscientific research, of fierce professional competition and the backlash of the antipsychiatry movement of the 1960s. A chemical treatment was developed for one purpose, and as long as some theoretical rationale could be found, doctors administered it to the insane patients in their care to see if it would help. Sometimes it did, dramatically. Why these treatments worked, Healy argues provocatively, was, and often still is, a mystery. Nonetheless, such discoveries made and unmade academic reputations and inspired intense politicking for the Nobel Prize.

Once pharmaceutical companies recognized the commercial potential of antipsychotic medications, financial as well as clinical pressures drove the development of ever more aggressively marketed medications. With verve and immense learning, Healy tells a story with surprising implications in a book that will become the leading scholarly work on its compelling subject.

Diapositiva anterior de detalles del producto
  1. Número de páginas
    416 páginas
  2. Idioma
    Inglés
  3. Editorial
    Harvard Univ Pr
  4. Fecha de publicación
    1 abril 2002
  5. Dimensiones
    16.51 x 3.18 x 23.5 cm
  6. ISBN-10
    0674006194
  7. ISBN-13
    978-0674006195
  8. Ver todos los detalles
Siguiente diapositiva de detalles del producto

Descripción del producto

Críticas

The standard historical view of psychiatry claims that the invention of chlorpromazine (a.k.a. Thorazine) in 1952 ushered in biologically based "scientific" psychiatry. Healy (The Antidepressant Era) claims that earlier psychiatry was also scientifically based and had some notable successes, such as the treatment of catatonia with shock therapy. Healy's second theme is that because the success of psychiatric drugs, the choice of treatment options is largely dependent on the financial preferences of the pharmaceutical industry. For example, the author argues that "randomized controlled trials" of drugs are favored by the pharmaceutical industry because they allow products to be marketed to a wide audience, but what is desperately needed is more research on the effects of medications on more specific types of patients. While this theme has certainly been sounded before (T.R. Luhrmann's Of Two Minds is an accessible discussion of the pitfalls of drug-based psychiatry), the detailed history of the development of psychiatric drugs and the "culture" surrounding them makes this book unique. For academic libraries. Mary Ann Hughes, Neill P.L., Pullman, WA
Copyright 2002 Cahners Business Information, Inc.

Críticas

David Healy is a respected historian of psychiatry who has written a book that should spark a major debate... -- Julie Wheelwright, The Independent [UK], May 7, 2002

Healy does groundbreaking work...The Creation of Psychopharmacology details how psychiatric medication intersects with academic squabbles and popular culture. -- Janice Paskey, Chronicle of Higher Education, January 25, 2002

[A] good place to start...to get an overview of the role of drugs in the treatment of mental illness. -- Richard Restak, Washington Times, March 25, 2002

Detalles del producto

  • Editorial ‏ : ‎ Harvard Univ Pr; Primera edición (1 abril 2002)
  • Idioma ‏ : ‎ Inglés
  • Pasta dura ‏ : ‎ 416 páginas
  • ISBN-10 ‏ : ‎ 0674006194
  • ISBN-13 ‏ : ‎ 978-0674006195
  • Dimensiones ‏ : ‎ 16.51 x 3.18 x 23.5 cm
  • Opiniones de los clientes:
    5.0 5.0 de 5 estrellas 12 calificaciones

Acerca del autor

Sigue a autores para obtener actualizaciones sobre los estrenos y mejores recomendaciones.
David Healy

David Healy

Brief content visible, double tap to read full content.
Full content visible, double tap to read brief content.

Descubre más sobre los libros del autor, ve autores similares, lee blogs del autor y más

Opiniones de clientes

5 de 5 estrellas
5 de 5
12 calificaciones globales

Las mejores reseñas de México

Hay 0 reseñas y 0 calificaciones de clientes de México

Mejores reseñas de otros países

Traducir todas las opiniones al Español
kent peterson
5.0 de 5 estrellas On time and in decent shape
Reseñado en los Estados Unidos el 25 de mayo de 2022
Compra verificada
Price was good
Reportar
hexedd
5.0 de 5 estrellas Excellent and Informative History of an Important Subject
Revisado en Canadá el 14 de junio de 2014
Compra verificada
This is an excellent book, and one that I believe everyone should read. Healy crafts an important narrative about how psychopharmacology began with good intentions, controlled largely by clinicians and universities, and was then co-opted by rising pharmaceutical companies that devised sneaky (and sometimes downright deceptive) manners in which to work within the law while effectively defining new illnesses for which they could provide the fix.

Perhaps Healy's most important point is that while industry (in this case big pharmaceuticals) will aim to provide a product that will alleviate or control psychiatric symptoms, their goal first and foremost is to create a larger profit margin. Thus, being accountable to shareholders, rather than the universities or clinicians that they have increasingly funded, "big pharma" acts in ways that often run counter to what the ostensible goal of psychiatry has been over the past one hundred years, i.e. finding pathologies and cures for mental illnesses.

Healy brilliantly shows how as the pharmaceutical industry grew in size and influence, the tacit goal became not to find a specific cure for specific illnesses, but to market drugs that were effective across a wide range of disorders to sell more product. Perhaps the most insidious part of the story is that in doing so, big pharmaceuticals devised ways to co-opt psychiatrists and university departments in order to define "new" illnesses of dubious character that they could then provide a fix for. ADHD stands out as one of the "star" illnesses that was, based on Healy's persuasive and varied evidence, created by companies. By controlling the evidence, and in many cases using ghost-written studies, they have been able to act within the FDA regulations while ignoring more effective medications simply because they are *too* specific and therefore less profitable.

The second main thread in Healy's narrative revolves around how psychopharmacology has over the past forty to fifty years been involved in the creation of a "biomedical self." Healy argues, quite persuasively, that as well as the 1960s being an era of liberation, it also created a more muddy definition of "health." Healy makes a strong point that as cosmetic pharmacology and surgeries have developed, it has been more difficult to define what illness is, and perhaps most importantly, our sense of self is tied directly to health matters and now largely defined by biomedical corporations.

Healy's work is an important one. It is far more than simply a "whistleblower's" account. This book provides an eye-opening history of how psychopharmacology in the early twenty first century is no longer in the hands of clinicians and researchers, but rather the companies that fund them. Perhaps the most ironic part of this history is that as health matters have become increasingly more technological and therefore more expensive, universities and other funding bodies that formerly controlled the flow of research and science no longer have the funds to do so. Thus, mental health matters are left in the hands of those who have profit concerns at the forefront of their minds and curing illness somewhere in back, if it is there at all.

For anyone who has ever been prescribed a medication, whether psychiatric or not, this book is a cautionary tale that not only asks the reader to question what is happening with big pharmaceuticals, but also asks us to look in the mirror and ask ourselves how much we have bought in (both figuratively and literally) to the biomedical self that has been defined for us.
Reportar
Lewis A. Opler
5.0 de 5 estrellas The best of times, the worst of times
Reseñado en los Estados Unidos el 7 de abril de 2014
Compra verificada
A remarkable view by someone who was there of the rise of modern psychopharmacology, with explanations of its progress as well as of missed opportunities due to pettiness by some and greed by others.
A 2 personas les resultó útil
 Reportar
Deanna Spingola
5.0 de 5 estrellas Five Stars
Reseñado en los Estados Unidos el 9 de julio de 2014
Compra verificada
Wonderful book!
Reportar